We recently analysed the expression of HER2, p53, and Ki67 in 506 invasive ductal carcinoma tissues and showed that the coexistence of HER2 overexpression and p53 protein accumulation was a strong prognostic molecular marker in breast cancer [11]. Here, ERBB2 is linked to breast carcinoma.